Abstract | BACKGROUND: METHODS: RESULTS: Thirteen tumors (4.9%) had EML4-ALK comprising 4 fusion transcript variants with fusion of the variable segments from 5' EML4 to 3' ALK and with preservation of the ALK kinase domain. The most common variant consisted of 8 tumors with variant 3 that involved EML4 exon 6. The others included 2 tumors with variant 1 (exon 13), 2 tumors with variant 2 (exon 20), and 1 tumor with the novel variant 5 (exon 18). There were 11 ADs and 2 unusual carcinomas with mixed squamous and glandular components. Immunohistochemistry demonstrated diffuse ALK fusion proteins in the tumor cell cytoplasm. EML4-ALK was associated with nonsmokers (P = .009). Tumors with the fusion gene had the wild-type epidermal growth factor receptor (EGFR) (P = .001) and v-Ki-ras2/Kirsten rat sarcoma viral oncogene homolog (KRAS) genes. Patients who had EML4-ALK-positive AD had a younger median age (P = .018) compared with patients who did not have the fusion gene. CONCLUSIONS: The EML4-ALK fusion gene was present in various histologic types of NSCLC. It occurred in mutual exclusion to EGFR and KRAS mutations and was associated with nonsmokers. The authors concluded that EML4-ALK may be useful for predicting the potential response to ALK inhibitors as a therapeutic option for patients with lung cancer.
|
Authors | Daisy Wing-Sze Wong, Elaine Lai-Han Leung, Kimpton Kam-Ting So, Issan Yee-San Tam, Alan Dart-Loon Sihoe, Lik-Cheung Cheng, Kwok-Keung Ho, Joseph Siu-Kie Au, Lap-Ping Chung, Maria Pik Wong, University of Hong Kong Lung Cancer Study Group |
Journal | Cancer
(Cancer)
Vol. 115
Issue 8
Pg. 1723-33
(Apr 15 2009)
ISSN: 0008-543X [Print] United States |
PMID | 19170230
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- EML4-ALK fusion protein, human
- Oncogene Proteins, Fusion
- ErbB Receptors
|
Topics |
- Aged
- Carcinoma, Non-Small-Cell Lung
(genetics, pathology)
- Chromosome Breakage
- ErbB Receptors
(genetics)
- Female
- Genes, ras
- Humans
- Lung Neoplasms
(genetics, pathology)
- Male
- Middle Aged
- Mutation
- Oncogene Proteins, Fusion
(genetics)
- Smoking
|